10x Insights
Loading account…
VGHCX

VANGUARD HEALTH CARE FUND

Actively managedEquityOpen-end fund
VANGUARD SPECIALIZED FUNDS: VGHCX · VGHAXHoldings as of Apr 30, 2026Filed Jun 26, 2026

Actively managed U.S. stock fund

2026 Q2 holdings and allocationChanges are against the previous quarter, 2026 Q1Headline fees and returns use the VGHCX share class
Expense ratio · VGHCX
0.33%
$33 a year for every $10,000 invested
0.27% – 0.33% across the 2 classes
$36.86B
The whole fund, all share classes
103 holdings
40.7%in the top 10
Weight held in the ten largest holdings
Top 25 hold 66.5%
Return, 1 year · VGHCX
+13.4%
With dividends, to Apr 2026
3 yr total +14.0% · 5 yr total +29.4%
What this fund is
Objective, as filed

Vanguard Health Care Fund (the Fund) seeks to provide long-term capital appreciation.

Strategy, summarised

The fund pursues long-term capital appreciation through active management, investing at least 80% of assets in stocks of companies engaged in health care development, production, or distribution—including pharmaceutical firms, medical suppliers, hospitals, and research-focused businesses—while seeking balanced representation across health care subsectors. The fund is nondiversified under the Investment Company Act of 1940, meaning it may invest a greater percentage of its assets in particular issuers than diversified funds, and it concentrates more than 25% of assets in health care securities as a matter of fundamental policy. Up to 50% of assets may be invested in foreign stocks.

What you own

per cent of the fund
CompanyWeightValue
9.08%
$3.35B
5.41%
$2.00B
AstraZeneca PLC
5.09%
$1.88B
3.92%
$1.44B
3.45%
$1.27B
3.21%
$1.18B
GSK PLC
3.13%
$1.15B
2.71%
$1.00B
2.35%
$868.21M
2.35%
$865.49M
Showing 1–10 of 103 · the top 10 are 40.71% of the fund, the top 25 are 66.52%

Reported price is the fund's own reported value divided by its own reported shares at 2026-04-30 — not a live quote, and not what the fund paid.

All 103 holdings, with the share counts as filed, open with a free account.

What the fund is made of

Percentages are of fund net assets. Rounding, liabilities and short positions can make totals differ from 100%.

99.72%
of net assets
Stocks98.41%
Cash & short-term1.31%

By sector

Health Care
75.6%
International
21.0%
Other
3.1%
Financials
0.3%
1 other sector
0.1%

How it has done

Total return, dividends reinvested · to Apr 2026

VGHCX share class · total returns with dividends reinvested

1 year
+13.41%
3 years
+14.03%
Cumulative, not per year
5 years
+29.37%
Cumulative, not per year
Largest decline in 3 years
-20.62%
From a previous high to a later low
Cumulative return, last three years· May 2023 – Apr 2026

Volatility over the last 12 months: 15.18%. Past returns are a record, not a forecast.

The 2 share classes hold the same portfolio

Share classExpense ratio1 year3 years5 yearsWorst fall
0.33%+13.41%+14.03%+29.37%-20.62%
0.27%+13.47%+14.18%+29.69%-20.58%

These classes hold the same portfolio, so the 0.32pp spread over 5 years is the cost difference between them — roughly 0.06pp a year — not a difference in what they own.

Fees & fund details

VANGUARD HEALTH CARE FUND is an actively managed U.S. equity fund.

Asset class
Equity
Region
United States
Management
Actively managed
Fund type
Open-end fund
Features
Non-diversified
Expense ratio, by class
0.27%0.33%· VGHCX 0.33%
Portfolio turnover
47.00% a year · as of 2026 Q2

Turnover is how much of the portfolio was replaced in a year.

Classified from what the fund holds, not from its name · 2026 Q2. The summary is a paraphrase of the prospectus; the objective is verbatim.

What changed this quarter

2026 Q2 vs 2026 Q1

Positions that entered or left the fund since its previous filing. Positions that were only resized are not listed.

7 new

Roche Holding AG
Ascendis Pharma A/S
Bridgebio Pharma IncBBIO
Stoke Therapeutics IncSTOK
Kailera Therapeutics IncKLRA

5 exited

Roche Holding AG
Ascendis Pharma A/S
Apellis Pharmaceuticals Inc
Astellas Pharma Inc
Soleno Therapeutics Inc
Connected research

Understand how this fund fits with the rest.

Explore shared holdings, compare funds and follow their businesses with your connected AI:

  • Where do my funds overlap — VGHCX, QQQ and the fund in my 401(k)?
  • How do this fund’s ten biggest holdings stack up against each other?
  • For my target-date fund, what’s the real stock-and-bond mix once you look through it?
See how it works →All research tools with a subscription. Use your own AI account.